VERRICA PHARMACEUTICALS INC (VRCA)       2.99  +0.07 (+2.4%)

2.99  +0.07 (+2.4%)

US92511W1080 - Common Stock - After market: 2.99 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 11.83. This target is 295.72% above the current price.
VRCA was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about VRCA.
In the previous month the buy percentage consensus was at a similar level.
VRCA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 2.994.0411.2211.8318.90 - 35.12% 275.25% 295.72% 532.11%

Up and Down Grades

Date Firm Action Rating
2022-05-31 HC Wainwright & Co. Maintains Buy
2022-05-25 RBC Capital Downgrade Outperform -> Sector Perform
2022-03-10 Brookline Capital Initiate Buy
2022-03-03 Needham Maintains Buy
2021-09-22 HC Wainwright & Co. Maintains Buy
2021-09-21 Needham Maintains Buy
2021-09-21 RBC Capital Maintains Outperform
2021-05-14 RBC Capital Initiate Outperform
2021-03-08 HC Wainwright & Co. Maintains Buy
2021-02-17 Needham Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA